Archive | ARTES Biotechnology GmbH

Home / Archive

France renews CIR tax credits for ARTES R&D services

Thursday 2nd April 2020

By ARTES Biotechnology… Learn More >

ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris

Monday 9th March 2020

By ARTES Biotechnology… Learn More >

ARTES VLP-based vaccine development

Thursday 19th September 2019

By ARTES Biotechnology… Learn More >

Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute

Friday 13th September 2019

By ARTES Biotechnology… Learn More >

ARTES presenting new development offer at BIOEurope Spring in Vienna

Tuesday 12th March 2019

By ARTES Biotechnology… Learn More >

Recombinant Protein Production and Purification: cell line and process development

Thursday 7th February 2019

By ARTES Biotechnology… Learn More >

ARTES adds SplitCore technology to vaccine development portfolio

Monday 7th January 2019

By ARTES Biotechnology… Learn More >

Vaccine development – ARTES

Wednesday 31st October 2018

By ARTES Biotechnology… Learn More >

ARTES and Minapharm join forces to package biopharma solutions

Monday 10th September 2018

By ARTES Biotechnology… Learn More >

Recombinant protein production – ARTES

Wednesday 8th August 2018

By ARTES Biotechnology… Learn More >

ARTES successfully completes EU-funded project PLURIVAX

Wednesday 18th April 2018

By ARTES Biotechnology… Learn More >

ARTES presenting protein production and vaccine development opportunities at BIO-Europe 2018

Monday 5th March 2018

By ARTES Biotechnology… Learn More >